Get started
BIOVICA INTERNATIONAL AB SER. BBIOVICA INTERNATIONAL AB SER. BBIOVICA INTERNATIONAL AB SER. B

BIOVICA INTERNATIONAL AB SER. B

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BIOVIC_B chart


Full chart

BIOVIC_B upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪166.96 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.410 SEK
Net income (FY)
‪−124.82 M‬ SEK
Revenue (FY)
‪7.29 M‬ SEK
Shares float
‪80.47 M‬
Beta (1Y)
0.02

Employees


Employees (FY)
37
Change (1Y)
+6 +19.35%
Revenue / Employee (1Y)
‪197.03 K‬ SEK
Net income / Employee (1Y)
‪−3.37 M‬ SEK

About BIOVICA INTERNATIONAL AB SER. B


Sector
Health Technology
Industry
Biotechnology
CEO
Anders Rylander
Website
biovica.com
Headquarters
Uppsala
Founded
2008
ISIN
SE0008613731
FIGI
BBG00GBNTM29
Biovica International AB is engages in the development and commercialization of novel blood-based biomarker assays to improve the monitoring of modern cancer therapies. It offers DiviTum assay, which is intended to monitor and predict treatment response in cancer patients. The company was founded in 2009 and is headquartered in Uppsala, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BIOVIC_B news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BIOVIC_B is 1.864 SEK — it has decreased by −8.01% in the past 24 hours. Watch BIOVICA INTERNATIONAL AB SER. B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BIOVICA INTERNATIONAL AB SER. B stocks are traded under the ticker BIOVIC_B.
BIOVIC_B stock has risen by 5.46% compared to the previous week, the month change is a −26.09% fall, over the last year BIOVICA INTERNATIONAL AB SER. B has showed a −29.66% decrease.
We've gathered analysts' opinions on BIOVICA INTERNATIONAL AB SER. B future price: according to them, BIOVIC_B price has a max estimate of 20.00 SEK and a min estimate of 3.20 SEK. Watch BIOVIC_B chart and read a more detailed BIOVICA INTERNATIONAL AB SER. B stock forecast: see what analysts think of BIOVICA INTERNATIONAL AB SER. B and suggest that you do with its stocks.
BIOVIC_B reached its all-time high on Jul 12, 2021 with the price of 68.274 SEK, and its all-time low was 1.400 SEK and was reached on Dec 19, 2024. View more price dynamics on BIOVIC_B chart.
See other stocks reaching their highest and lowest prices.
BIOVIC_B stock is 41.11% volatile and has beta coefficient of 0.02. Track BIOVICA INTERNATIONAL AB SER. B stock price on the chart and check out the list of the most volatile stocks — is BIOVICA INTERNATIONAL AB SER. B there?
Today BIOVICA INTERNATIONAL AB SER. B has the market capitalization of ‪166.52 M‬, it has decreased by −2.49% over the last week.
Yes, you can track BIOVICA INTERNATIONAL AB SER. B financials in yearly and quarterly reports right on TradingView.
BIOVICA INTERNATIONAL AB SER. B is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOVIC_B earnings for the last quarter are −0.27 SEK per share, whereas the estimation was −0.24 SEK resulting in a −11.60% surprise. The estimated earnings for the next quarter are −0.28 SEK per share. See more details about BIOVICA INTERNATIONAL AB SER. B earnings.
BIOVICA INTERNATIONAL AB SER. B revenue for the last quarter amounts to ‪2.16 M‬ SEK, despite the estimated figure of ‪5.45 M‬ SEK. In the next quarter, revenue is expected to reach ‪3.55 M‬ SEK.
BIOVIC_B net income for the last quarter is ‪−21.15 M‬ SEK, while the quarter before that showed ‪−22.89 M‬ SEK of net income which accounts for 7.59% change. Track more BIOVICA INTERNATIONAL AB SER. B financial stats to get the full picture.
No, BIOVIC_B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 37.00 employees. See our rating of the largest employees — is BIOVICA INTERNATIONAL AB SER. B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOVICA INTERNATIONAL AB SER. B EBITDA is ‪−103.38 M‬ SEK, and current EBITDA margin is ‪−1.67 K‬%. See more stats in BIOVICA INTERNATIONAL AB SER. B financial statements.
Like other stocks, BIOVIC_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOVICA INTERNATIONAL AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOVICA INTERNATIONAL AB SER. B technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOVICA INTERNATIONAL AB SER. B stock shows the sell signal. See more of BIOVICA INTERNATIONAL AB SER. B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.